FDA
-
-
-
-
-
-
-
180 Life Sciences Corp (ATNF) Receives Written Scientific Response from the UK MHRA Following August Meeting
-
-
-
-
-
-
-
180 Life Sciences Corp. Announces the Filing of a Provisional Patent Describing the Combination of CBD With GLP-1 Agonists to Suppress Appetite
-
-
-
-
-
-
-
180 Life Sciences Announces Allowance of Claims for a US Patent for Dupuytren’s Disease Treatment and Application
-
-
-
-
-
-
-
180 Life Sciences Engages Kinexum for Assistance in Applying for Marketing Authorisation in the United Kingdom
-
-
-
-
-
-
-
180 Life Sciences Corp. Announces $6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
-
-
-
-
-
-
-
180 Life Sciences to Participate in A.G.P.’s Virtual Biotech Conference to be Held November 30 – December 1, 2022
-
-
-
-
-
-
-
180 Life Sciences Issues Letter to Stockholders
-
251,637 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All